Solid stock: buy or sell?
July 16th, 2019
Solid Biosciences, LLC engages in identifying and developing gene therapies for duchenne muscular dystrophy in the United States.
Should I buy Solid stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Solid stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Solid stock a buy?
Banks and financial institutions publish stock ratings everyday.At Stocks2.com, we collected 5 ratings published for SLDB stock in the last 30 days. The general sentiment of these ratings is bearish for SLDB stock, with 2 negative ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-5-14||Goldman Sachs Group||Neutral||Sell|
|2019-5-14||Credit Suisse Group||Neutral||Underperform|
|2019-2-8||Svb Leerink||Outperform||Market Perform|
Solid stock analysis
Solid Biosciences fell a rough -2.10% and closed at $5.14.
Solid shares fell -2.10% to $5.14 today.
Shares of Solid Biosciences dropped a rough -3.20% this week. Late June SLDB rocketed a super good 12.87% in just one week. Early July SLDB collapsed a frightening -10.79% in just one week.
Solid stock price history
Solid stock went public on January 26th, 2018 with a price of $25.501. Since then, SLDB stock sliced a -79.80%, with a yearly average of -79.80%.
1: Adjusted price after possible price splits or reverse-splits.
Solid stock historical price chart
SLDB stock reached 52-week highs on September at $54.54, and all-time highs 2018-06-19 with a price of 54.84.
Solid stock price target is $10.50Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. You should not follow the analysts' SLDB stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we found 2 price targets for SLDB stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-5-14||Credit Suisse Group||Downgrades||$7.00||$6.00||-14.3%|
Financials and fundamental analysis
Earnings date and Earnings per ShareOn March, Solid Biosciences presented its financial report, posting a remarkable climb for the Earnings per Share (EPS) ratio. Analyst expected $-0.58 per share, but Solid posted $-0.67.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to , last anual sales report draw of to million USD. , its profit margin (compared to revenues) to , that is million.
Quarterly financial resultsReported quarter earnings marked $-21.92 M with a profit margin of . Profit margin remained steady a 0.00% compared to previous quarter when profit margin was inf%. When comparing revenues to same quarter last year, Solid Biosciences sales marked a neutral movement and remained constant a nan%. Looking back to recent quarterly results, Solid posted 5 positive quarters in a row.
Solid ownershipWhen you are planning to invest in shares of a stock, it's always worth to have a look its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Solid, 34.71% of all outstanding shares are owned by its staff.
In case of Solid Biosciences stock, 77.40% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for SLDB stock account 0.00%, no big difference from last month.
For a better context understanding, the next table shows ownership data compared to other related companies:
|Market cap||$182.0 M|
|Total shares||35.4 M|
|Float shares||10.4 M|
|- Institutional holdings (%)||77.4%|
|- Insider holdings (%)||34.7%|
|Shares in short selling||0.0%|
|Tuesday, July 16th, 2019|
|Day range||$5.11 - $5.35|
|Average true range||$0.48|
|50d mov avg||$5.86|
|100d mov avg||$7.82|
|200d mov avg||$18.03|
Solid performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. We chose as the bechmarking frame for Solid stock.